Over 1650 Total Lots Up For Auction at Four Locations - NJ 04/25, MA 04/30, NJ Cleansweep 05/02, NJ 05/08

Spanish Spanish

University of Minnesota first in U.S. to offer new targeted therapy for recurrent brain tumors

Press releases may be edited for formatting or style | February 14, 2019 Rad Oncology
Share


About the University of Minnesota Medical School
The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians. Our graduates and faculty produce high-impact biomedical research and advance the practice of medicine.

Back to HCB News
Sign up for Rad Oncology stories Sign up for Weekly Top stories

You Must Be Logged In To Post A Comment

Sign up for Weekly Top stories

Sign up for Rad Oncology stories

 

Rad Oncology Homepage

Raigmore Hospital in Scotland selects RayCare
GT Medical Technologies completes strategic acquisition of radioactive seed assets from Perspective Therapeutics, Inc.
World leading carbon ion center QST in Japan selects RayStation
NAPT Honors Proton Therapy Caregivers, Advocates with First Annual Excellence Awards
Oklahoma Proton Center celebrates milestone achievement: 5,000th patient successfully treated
Two clinical studies show high-risk and recurrent prostate cancers can be treated in five days with Accuray CyberKnife
RefleXion and Limbus AI announce technology integration to expedite cancer treatment planning
C-RAD receives an order of 12 MSEK from Italy, related to an extension of the national Consip tender
Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients
New MR/ultrasound treatment option for prostate cancer shows successful outcomes